The glycine transport inhibitor sarcosine is an inhibitory glycine receptor agonist

Neuropharmacology

Volumn 57, Issue 5-6, 2009, Pages 551-555

  Zhang, Hai Xia ^a   Lyons Warren, Ariel ^a   Thio, Liu Lin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Culture; Hippocampus; N Methyl d aspartate; N 3 (4 fluorophenyl) 3 (4 phenylphenoxy)propyl sarcosine; Patch clamp; Schizophrenia

Indexed keywords

GLYCINE; GLYCINE RECEPTOR AGONIST; GLYCINE RECEPTOR ANTAGONIST; GLYCINE TRANSPORTER 1; LITHIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; N[3 (4' FLUOROPHENYL) 3 (4' PHENYLPHENOXY)PROPYL]SARCOSINE; SARCOSINE; STRYCHNINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHLORIDE CURRENT; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; EMBRYO; EMBRYO CELL; EVOKED RESPONSE; FEMALE; GLIA; HIPPOCAMPUS; ION EXCHANGE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; WHOLE CELL;

ANIMALS; CELLS, CULTURED; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; GLYCINE; GLYCINE AGENTS; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HIPPOCAMPUS; LITHIUM; MICE; NEUROGLIA; NEURONS; PATCH-CLAMP TECHNIQUES; RECEPTORS, GLYCINE; SARCOSINE; STRYCHNINE;

EID: 69649088118     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.019     Document Type: Article

References (28)

1. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., and Amara S.G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14 (1994) 5559-5569
2. Bergeron F., Otto A., Blache P., Day R., Denoroy L., Brandsch R., and Bataille D. Molecular cloning and tissue distribution of rat sarcosine dehydrogenase. Eur. J. Biochem. 257 (1998) 556-561
3. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26 (2006) 365-384
4. Deutsch S.I., Rosse R.B., Long K.D., Gaskins B., and Mastropaolo J. Rare neurodevelopmental abnormalities of sarcosinemia may involve glycinergic stimulation of a primed N-methyl-d-aspartate receptor. Clin. Neuropharmacol 29 (2006) 361-363
5. Eulenburg V., Armsen W., Betz H., and Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci. 30 (2005) 325-333
6. Herdon H.J., Godfrey F.M., Brown A.M., Coulton S., Evans J.R., and Cairns W.J. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes. Neuropharmacology 41 (2001) 88-96
7. Huang H., Barakat L., Wang D., and Bordey A. Bergmann glial GlyT1 mediates glycine uptake and release in mouse cerebellar slices. J. Physiol. 560 (2004) 721-736
8. Javitt D.C. Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification. Curr. Opin. Drug Discov. Devel 12 (2009) 468-478
9. Lane H.Y., Chang Y.C., Liu Y.C., Chiu C.C., and Tsai G.E. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. Arch. Gen. Psychiatry 62 (2005) 1196-1204
10. Lane H.Y., Liu Y.C., Huang C.L., Chang Y.C., Liau C.H., Perng C.H., and Tsai G.E. Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol. Psychiatry 63 (2008) 9-12
11. Lopez-Corcuera B., Martinez-Maza R., Nunez E., Roux M., Supplisson S., and Aragon C. Differential properties of two stably expressed brain-specific glycine transporters. J. Neurochem. 71 (1998) 2211-2219
12. Mallorga P.J., Williams J.B., Jacobson M., Marques R., Chaudhary A., Conn P.J., Pettibone D.J., and Sur C. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4′-fluorophenyl)-3-(4′phenylphenoxy)propyl])sarcosine. Neuropharmacology 45 (2003) 585-593
13. Martina M., Gorfinkel Y., Halman S., Lowe J.A., Periyalwar P., Schmidt C.J., and Bergeron R. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. J. Physiol. 557 (2004) 489-500
14. Matalon R., Naidu S., Hughes J.R., and Michals K. Nonketotic hyperglycinemia: treatment with diazepam-a competitor for glycine receptors. Pediatrics 71 (1983) 581-584
15. A receptors in cultured murine cerebellar granule cells. Neurosci. Lett. 286 (2000) 25-28
16. Scott C.R. Sarcosinemia. In: Scriver C.R., Beaudet A.L., Valle D., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw Hill, Medical Publishing Division, New York 2057-2063
17. Sergeeva O.A., Chepkova A.N., and Haas H.L. Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. Br. J. Pharmacol. 137 (2002) 855-860
18. Shim S.S., Hammonds M.D., and Kee B.S. Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci. 258 (2008) 16-27
19. Smith K.E., Borden L.A., Hartig P.R., Branchek T., and Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8 (1992) 927-935
20. Thio L.L., Clifford D.B., and Zorumski C.F. Characterization of quisqualate receptor desensitization in cultured postnatal rat hippocampal neurons. J. Neurosci. 11 (1991) 3430-3441
21. 2-containing inhibitory glycine receptors in embryonic mouse hippocampal neurons. J. Neurophysiol 90 (2003) 89-99
22. Thio L.L., and Yamada K.A. Differential presynaptic modulation of excitatory and inhibitory autaptic currents in cultured hippocampal neurons. Brain Res. 1012 (2004) 22-28
23. Tsai G., Lane H.Y., Yang P., Chong M.Y., and Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry 55 (2004) 452-456
24. Ueland P.M., Midttun O., Windelberg A., Svardal A., Skalevik R., and Hustad S. Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin. Chem. Lab. Med. 45 (2007) 1737-1745
25. Zhang H., and Thio L.L. Sarcosine, an antischizophrenic agent and glycine transporter I inhibitor, is an inhibitory glycine receptor agonist and NMDA receptor antagonist. 2008 Neuroscience Meeting Planner Online Program No. 55.13 (2008)
26. Zhang H.X., Hyrc K., and Thio L.L. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J. Physiol. 587 (2009) 3207-3220
27. Zhang H.X., and Thio L.L. Zinc enhances the inhibitory effects of strychnine-sensitive glycine receptors in mouse hippocampal neurons. J. Neurophysiol 98 (2007) 3666-3676
28. Zhang L.H., Gong N., Fei D., Xu L., and Xu T.L. Glycine uptake regulates hippocampal network activity via glycine receptor-mediated tonic inhibition. Neuropsychopharmacology 33 (2008) 701-711